Amicus Therapeutics is a biopharmaceutical company which is located in New Jersey. A biopharmaceutical is a prescription for patients that is used for their blood. They are an advanced therapy corporation that finds solutions for rare diseases. The product that serves the most customers is called migalastat. Migalastat treats patients in their late-stage development of Fabry disease. Another product is called SD-101 for the rare disease of connective tissue disorder called Epidermolysis Bullosa. Amicus Therapeutics serves their patients these products according to their disorders.
Amicus Therapeutics is a dedicated team in helping treat rare orphan diseases (Philly Purge). They continue to advance in their products. They use the platform CHART (Chaperone-Advanced Replacement Therapy) technologies for their products. Amicus Therapeutics continue to develop for Fabry Disease, Pompe disease, and other LSDs. Their outstanding biological program is ATB200/AT2221 along with a pharmacological chaperone to watch over the uses of these products on patients (http://weeklyopinion.com/2017/08/amicus-therapeutics-announces-the-launch-of-new-drug/). Amicus Therapeutics focuses their products for rare orphan diseases. This is defined as a condition affecting almost 200,000 people, including Lou Gehrig’s disease, Tourette’s Syndrome, Hamburger disease, and Job syndrome.
Since people around the world are in need of their specific disease to be diagnosed, Amicus Therapeutics has an inventive science, commercial, and clinical programs. This company wants to make a difference in the world by helping patients be more healthy to make their lives more meaningful.
As science continues to make new discoveries in medicine, they continue in their search for better ways to help their fellow people become healthy. It is important to be a healthy individual because people have their parts in their community to help one another, whether that is a caregiver, cook, entertainer, or teacher. It is important to help one another survive and create a better tomorrow free of diseases.
As a result, science is a good outlet for people who want to make new discoveries. And companies like Amicus Therapeutics are here to invest in those willing to create a difference for the world.